In October, CVS Health entered into an agreement with the Department of Justice to move forward with its acquisition of Aetna, with the caveat Aetna would sell its stand-alone Medicare Part D prescription drug plans to WellCare.
WellCare will assume control of Aetna’s 2.2 million-member business, but Aetna will provide administrative services for the Part D business and take on financial risk associated with the unit through 2019. As a result, WellCare doesn’t expect the deal to affect its operations until 2020.
More articles on payers:
Anthem’s retroactive denial policy keeps patients from seeking care, physicians say
Trump administration is promoting Medicare Advantage
Walgreens CEO says he’s open to expansion of Humana partnership on senior health clinics
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
